Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease

Neuroscience Letters

Volumn 368, Issue 2, 2004, Pages 140-143

  Nishimura, Masataka ^a   Sakamoto, Toshiyo ^b   Kaji, Ryuji ^b   Kawakami, Hideshi ^c  

^a Konan Hospital   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Cytokine; Glutathione S transferase omega (GSTO); IL 6; Interleukin (IL) 1 ; Polymorphism; Transforming growth factor (TGF) 1

Indexed keywords

CYTOKINE; GLUTATHIONE TRANSFERASE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 4444324424     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.06.076     Document Type: Article

References (19)

1. L. Araria-Goumidi, J.C. Lambert, D.M.A. Mann, C. Lendon, B. Frigard, T. Iwatsubo, D. Cottel, P. Amouyel, and M.C. Chartier-Harlin Association study of three polymorphisms of TGF-β1 gene with Alzheimer's disease J. Neurol. Neurosurg. Psychiatry 73 2002 62 64
2. J.S. Collins, R.T. Perry, B. Watson Jr., L.E. Harrell, R.T. Acton, D. Blacker, M.S. Albert, R.E. Tanzi, S.S. Bassett, M.G. Mclnnis, R.D. Campbell, and R.C. Go Associations of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative Am. J. Med. Genet. 96 2000 823 830
3. O. Combarros, M. Sanches-Guerra, J. Infante, J. Llorca, and J. Berciano Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease J. Neurol. 249 2002 1242 1245
4. W.S. Griffin, J.G. Sheng, M.C. Royston, S.M. Gentleman, J.E. McKenzie, D.I. Graham, G.W. Roberts, and R.E. Mrak Glial-neuronal interactions in Alzheimer's disease: the potential role of a "cytokine cycle" in disease progression Brain Pathol. 8 1998 65 72
5. A. Heils, K. Haug, W.S. Kunz, G. Fernandez, S. Horvath, J. Rebstock, P. Propping, and C.E. Elger Interleukin-1beta gene polymorphism and susceptibility to temporal lobe epilepsy with hippocampal sclerosis Ann. Neurol. 48 2000 948 950
6. M. Hull, M. Berger, B. Volk, and J. Bauer Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques Ann. N. Y. Acad. Sci. 777 1996 205 212
7. K. Kanemoto, J. Kawasaki, T. Miyamoto, H. Obayashi, and M. Nishimura Interleukin (IL)-1β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy Ann. Neurol. 47 2000 571 574
8. C.S. Ki, D.L. Na, D.K. Kim, H.J. Kim, and J.W. Kim Lack of association of the interleukin-1 alpha gene polymorphism with Alzheimer's disease in a Korean population Ann. Neurol. 49 2001 817 818
9. R.E. Laliberte, D.G. Perregaux, L.R. Hoth, P.J. Rosner, C.K. Jordan, K.M. Peese, J.F. Eggler, M.A. Dombroski, K.F. Geoghegen, and C.A. Gabel Glutathione S-transferase omega-1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1b posttranslational processing J. Biol. Chem. 278 2003 16567 16578
10. Y.J. Li, S.A. Oliveira, P. Xu, E.R. Martin, J.E. Stenger, C.R. Scherzer, M.A. Hauser, W.K. Scott, G.W. Small, M.A. Nance, R.L. Watts, J.P. Hubble, W.C. Koller, R. Pahwa, M.B. Stern, B.C. Hiner, J. Jankovic, C.G. Goetz, F. Mastaglia, L.T. Middleton, A.D. Roses, A.M. Saunders, D.E. Schmechel, S.R. Gullans, J.L. Haines, J.R. Gilbert, J.M. Vance, and M.A. Pericak-Vance Glutathione S-transferase omega 1 modifies age-at-onset of Alzheimer disease and Parkinson disease Hum. Mol. Genet. 12 2003 3259 3267
11. D. Lio, F. Licastro, L. Scola, M. Chiappelli, L.M. Grimaldi, A. Crivello, G. Colonna-Romano, G. Candore, C. Franceschi, and C. Caruso Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease Genes. Immun. 4 2003 234 238
12. E.K. Luedecking, S.T. DeKosky, H. Mehdi, M. Ganguli, and M.I. Kamboth Analysis of genetic polymorphisms in the transforming growth factor-β1 gene and the risk of Alzheimer's disease Hum. Genet. 106 2000 565 569
13. P.L. McGeer, and E.G. McGeer Polymorphisms in inflammatory genes and the risk of Alzheimer's disease Arch. Neurol. 58 2001 1790 1792
14. P.L. McGeer, M. Schulzer, and E.G. McGeer Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies Neurology 47 1996 425 432
15. G. McKahn, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease Neurology 34 1984 939 944
16. M. Nishimura, M. Maeda, J. Yasunaga, H. Kawakami, R. Kaji, A. Adachi, T. Uchiyama, and M. Matsuoka Influence of cytokine and mannose binding protein gene polymorphisms on human T-cell leukemia virus type I (HTLV-I) provirus load in HTLV-I asymptomatic carriers Hum. Immunol. 64 2003 453 457
17. A. Papassotiropoulos, M. Bagli, F. Jessen, T.A. Bayer, W. Maier, M.L. Rao, and R. Heun A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease Ann. Neurol. 45 1999 666 668
18. S.J. Tsai, H.C. Liu, T.Y. Liu, K.Y. Wang, and C.J. Hong Lack of association between the interleukin-1 alpha gene C (-889) T polymorphism and Alzheimer's disease in a Chinese population Neurosci. Lett. 343 2003 93 96
19. T. Wyss-Coray, E. Masliah, M. Mallory, L. McConlogue, K. Johnson-Wood, C. Lin, and L. Mucke Amyloidgenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease Nature 389 1997 603 606